Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.928 SEK | -0.85% | +1.98% | -24.55% |
11/06 | Nanexa AB Announces That First Patient Dosed in Nanexa's Phase I Trial of NEX-22 in Type 2 Diabetes | CI |
15/05 | Nanexa AB Elects Hanna Tilus as Members of the Board | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NANEXA AB | Drug Delivery Systems | -0.85% | +1.98% | -24.55% | -72.71% | -90.72% | 12.12M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- NANEXA Stock
- Charts Nanexa AB
- Comparison Chart